Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
Eur Heart J Acute Cardiovasc Care. 2013 Mar;2(1):19-26. doi: 10.1177/2048872612469885.
To compare the performance of the CRUSADE, ACUITY-HORIZONS, and ACTION risk models in the ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI).
We studied all consecutive patients with STEMI who underwent PPCI at our institution between 2006 and 2010 (n=1391). The CRUSADE, ACUITY-HORIZONS, and ACTION risk scores were calculated based on the patients' clinical characteristics. The occurrence of in-hospital major bleeding (defined as the composite of intracranial or intraocular bleeding, access site haemorrhage requiring intervention, reduction in haemoglobin ≥4 g/dl without or ≥3g/dl with overt bleeding source, reoperation for bleeding, or blood transfusion) reached 9.8%. Calibration and discrimination of the three risk models were evaluated by the Hosmer-Lemeshow test and the C-statistic, respectively. We compared the predictive accuracy of the risk scores by the DeLong non-parametric test.
Calibration of the three risk scores was adequate, given the non-significant results of Hosmer-Lemeshow test for the three risk models. Discrimination of CRUSADE, ACUITY-HORIZONS, and ACTION models was good (C-statistic 0.77, 0.70, and 0.78, respectively). The CRUSADE and ACTION risk scores had a greater predictive accuracy than the ACUITY-HORIZONS risk model (z=3.89, p-value=0.0001 and z=3.51, p-value=0.0004, respectively). There was no significant difference between the CRUSADE and ACTION models (z=0.63, p=0.531).
The CRUSADE, ACUITY-HORIZONS, and ACTION scores are useful tools for the risk stratification of bleeding in STEMI treated by PPCI. Our findings favour the CRUSADE and ACTION risk models over the ACUITY-HORIZONS risk score.
比较 CRUSADE、ACUITY-HORIZONS 和 ACTION 风险模型在接受直接经皮冠状动脉介入治疗(PPCI)的 ST 段抬高型心肌梗死(STEMI)患者中的表现。
我们研究了 2006 年至 2010 年期间在我院接受 PPCI 的所有连续 STEMI 患者(n=1391)。基于患者的临床特征,计算了 CRUSADE、ACUITY-HORIZONS 和 ACTION 风险评分。住院期间主要出血的发生率(定义为颅内或眼内出血、需要介入的入路部位出血、血红蛋白下降≥4g/dl 而无明显出血源或≥3g/dl 伴明显出血源、因出血再次手术或输血)为 9.8%。通过 Hosmer-Lemeshow 检验和 C 统计量分别评估了三种风险模型的校准和区分能力。我们通过 DeLong 非参数检验比较了风险评分的预测准确性。
三个风险评分的校准是充分的,因为三个风险模型的 Hosmer-Lemeshow 检验结果均无统计学意义。CRUSADE、ACUITY-HORIZONS 和 ACTION 模型的区分能力良好(C 统计量分别为 0.77、0.70 和 0.78)。CRUSADE 和 ACTION 风险评分的预测准确性优于 ACUITY-HORIZONS 风险模型(z=3.89,p 值=0.0001 和 z=3.51,p 值=0.0004)。CRUSADE 和 ACTION 模型之间无显著差异(z=0.63,p=0.531)。
CRUSADE、ACUITY-HORIZONS 和 ACTION 评分是用于 PPCI 治疗 STEMI 患者出血风险分层的有用工具。我们的发现表明,CRUSADE 和 ACTION 风险模型优于 ACUITY-HORIZONS 风险评分。